Patent details

EP2124947 Title: DOSAGE REGIMEN FOR COMT INHIBITORS

Basic Information

Publication number:
EP2124947
PCT Application Number:
PT2007000043
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP078349115
PCT Publication Number:
WO2008094053
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DOSAGE REGIMEN FOR COMT INHIBITORS
French Title of Invention:
SCHÉMA POSOLOGIQUE POUR DES INHIBITEURS DE LA CATÉCHOL-O-MÉTHYLTRANSFÉRASE
German Title of Invention:
DOSIERSCHEMA FÜR COMT-HEMMER
SPC Number:

Dates

Filing date:
10/10/2007
Grant date:
19/07/2017
EP Publication Date:
02/12/2009
PCT Publication Date:
07/08/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/07/2017
EP B1 Publication Date:
19/07/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
10/10/2017
Expiration date:
10/10/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/07/2017
 
 

Name:
BIAL - Portela & Ca., S.A.
Address:
À Av. da Siderurgia Nacional, 4745-457 S. Mamede do Coronado, Portugal (PT)

Inventor

1

Name:
SILVA, Patrício Manuel Vieira Araújo Soares da
Address:
Portugal (PT)

2

Name:
LEARMONTH, David Alexander
Address:
Portugal (PT)

3

Name:
PALMA, Pedro Nuno Leal
Address:
Portugal (PT)

4

Name:
KISS, Laszlo Erno
Address:
Portugal (PT)

5

Name:
FERREIRA, Humberto dos Santos
Address:
Portugal (PT)

Priority

Priority Number:
07002091
Priority Date:
31/01/2007
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 31/4439; A61P 25/16;

Publication

European Patent Bulletin

Issue number:
201729
Publication date:
19/07/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
28/02/2018 Outgoing Correspondence 1